News
Filter
-
The Aisling Burnand Daphne Jackson Research Fellowship, sponsored by LifeArc
-
Honouring the contribution of a remarkable trustee – Aisling Burnand CBE
-
Rare Disease Day 2023 – Robbie’s story
-
Four ways we support rare disease research
-
LifeArc awards £3 million to advance promising early rare disease research from the lab to the patient
-
LifeArc Ventures invests in Maxion Therapeutics
-
Celebrating the International Day of Women and Girls in Science
-
LifeArc Ventures – strong performance in 2022 & sustained investment in innovation
-
£1 million awarded to develop cutting-edge therapies for motor neuron disease
-
LifeArc portfolio company RQ Bio’s antibody enters clinical trials
-
Alzheimer’s drug lecanemab approved by US regulator
-
Evolving our science to solve complex healthcare challenges
